We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Looking forward

4 Nov 2021 By Jennifer Hughes

The Asian indemnifier added China risk factors to its U.S. prospectus even though it doesn’t operate there. It feels like a last-ditch attempt to secure SEC approval before any buzz dies down. The Hong Kong bourse, which probably should have been Plan A, makes a suitable Plan B.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)